LoginSignup
ALU

Allurion Tech

Stock
Stock
ISIN: US02008G1022
Ticker: ALUR
US02008G1022
ALUR

Price

Price

CHART BY

Frequently asked questions

What is Allurion Tech's market capitalization?

The market capitalization of Allurion Tech is $22.55M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Allurion Tech?

Allurion Tech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.476. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Allurion Tech's stock?

Currently, 4 analysts cover Allurion Tech's stock, with a consensus target price of $1.833. Analyst ratings provide insights into the stock's expected performance.

What is Allurion Tech's revenue over the trailing twelve months?

Over the trailing twelve months, Allurion Tech reported a revenue of $34.75M.

What is the EBITDA for Allurion Tech?

Allurion Tech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$57.65M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Allurion Tech?

Allurion Tech has a free cash flow of -$50.91M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Allurion Tech have, and what sector and industry does it belong to?

Allurion Tech employs approximately 252 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Allurion Tech's shares?

The free float of Allurion Tech is 47.04M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$22.55M
EPS (TTM) 
-$0.476
Free Float 
47.04M
Revenue (TTM) 
$34.75M
EBITDA (TTM) 
-$57.65M
Free Cashflow (TTM) 
-$50.91M

Pricing

52W span
$0.262$4.00

Analyst Ratings

The price target is $1.833 and the stock is covered by 4 analysts.

Buy

3

Hold

1

Sell

0

Information

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.

Employees
252
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
US02008G1022
Primary Ticker
ALUR
Join the conversation
Sign upLogin